Company
Every investor coverage indicates participated in a round Atomo Diagnostics raised.
Companies Atomo Diagnostics acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| John Kelly | CEO | @AuManufacturing |
Stories naming Atomo Diagnostics. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Manufacturing news roundup: GreenHY2 and Atomo Diagnostics receive government grants, Seaport Therapeutics closes a US$225m Series B, Orthocell secures $17m, Genevo Marine opens a crowdfunding offer, and the ACCC clears Accolade's wine acquisition.
Federal grants roundup: 21 Cooperative Research Centres Projects awards worth $51 million in Round 15, with EQ Plastics, Optiscan Imaging and NEXSEN BioTech each receiving $3 million for product development.
Also RenewEconomy
News roundup covering Atomo Diagnostics' committed share placement, Tivan's port agreement, KBR's reconciliation plan, Elexon's innovation award, ReNu Energy's hydrogen refuelling brand and EQ Resources' new ore sorter.
A manufacturing roundup covering Hazer's R&D tax refund, Atomo's South African test supply deal, Acrow's asset purchase, PureFoods' product revenue, a solar farm completion, BlueScope's accelerator applications, and a drone modem launch.
NSW Government's 2016 Medical Devices Fund awarded $8.6 million to four medtech companies, Elastagen getting $4 million; earlier winners Saluda Medical and Atomo Diagnostics also feature, the latter having lately drawn Gates Foundation money.